New Injectable on the horizon targets the chin

http://wrinkleinjections.blogspot.ca/2012/10/new-injectable-on-horizon-targets.html

The advent of Facebook, the IPhone and Skype has placed the double chin front and center. Certainly, the image of yourself you see, using any of these devices, face pointed downward, is likely to be with folds of chin fat.

 Kythera Biopharmaceuticals is capitalizing on this trend. They went public in October 2012 on the strength of ATX-101, an injectable drug aimed at reducing the double chin.